S.B. Cannady
Papers
1
Total Citations
2
H-Index
1
About
Dr. S.B. Cannady is a leading head and neck surgical oncologist whose research focuses on de-intensification strategies for HPV-related oropharyngeal cancers, particularly through transoral robotic surgery (TORS). Their most cited work, a Phase II study from 2022, investigates volume and dose de-intensification following TORS and neck dissection for p16+ oropharyngeal squamous cell carcinoma—a paradigm-shifting approach that aims to reduce treatment toxicity while maintaining excellent oncologic outcomes. With 2 citations to date, this study is gaining traction among clinicians seeking to minimize long-term side effects like dysphagia and xerostomia in younger, healthier patients. Dr. Cannady’s contributions are pivotal in refining surgical protocols and establishing evidence-based criteria for de-escalation, directly impacting clinical guidelines. Their work bridges surgical innovation with patient-centered care, offering a roadmap for personalized treatment in HPV-driven head and neck cancers. For students and researchers, Dr. Cannady exemplifies how targeted surgical research can transform standard-of-care practices, balancing efficacy with quality of life.
Research Focus
Key Achievements
Top Papers
- 1